Profile | GDS5420 / 226878_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 261.51 | 56 |
GSM1296119 | B_lesional_pre-dose | 738.23 | 74 |
GSM1296076 | C_lesional_pre-dose | 432.88 | 66 |
GSM1296092 | D_lesional_pre-dose | 654.6 | 72 |
GSM1296103 | E_lesional_pre-dose | 702.36 | 73 |
GSM1296078 | F_lesional_pre-dose | 478.92 | 68 |
GSM1296107 | G_lesional_pre-dose | 401.94 | 64 |
GSM1296109 | H_lesional_pre-dose | 320.01 | 59 |
GSM1296080 | I_lesional_pre-dose | 217.06 | 55 |
GSM1296090 | J_lesional_pre-dose | 898.11 | 77 |
GSM1296074 | K_lesional_pre-dose | 695.35 | 74 |
GSM1296111 | L_lesional_pre-dose | 627.14 | 72 |
GSM1296099 | M_lesional_pre-dose | 753.06 | 74 |
GSM1296086 | O_lesional_pre-dose | 851.55 | 76 |
GSM1296117 | P_lesional_pre-dose | 406.53 | 64 |
GSM1296113 | Q_lesional_pre-dose | 556.38 | 69 |
GSM1296096 | R_lesional_pre-dose | 558.54 | 69 |
GSM1296105 | S_lesional_pre-dose | 359.67 | 61 |
GSM1296098 | T_lesional_pre-dose | 265.3 | 57 |
GSM1296101 | U_lesional_pre-dose | 683.88 | 73 |
GSM1296121 | V_lesional_pre-dose | 429.97 | 65 |
GSM1296088 | W_lesional_pre-dose | 680.48 | 73 |
GSM1296082 | X_lesional_pre-dose | 743.37 | 74 |
GSM1296115 | Y_lesional_pre-dose | 384.12 | 63 |
GSM1296084 | Z_lesional_pre-dose | 467.23 | 67 |
GSM1296072 | B_lesional_day8 | 718.62 | 74 |
GSM1296069 | L_lesional_day8 | 568.37 | 70 |
GSM1296071 | P_lesional_day8 | 683.26 | 73 |
GSM1296070 | Y_lesional_day8 | 560.78 | 69 |
GSM1296073 | V_lesional_day8 | 603.92 | 71 |
GSM1296034 | A_lesional_day15 | 303.77 | 58 |
GSM1296041 | G_lesional_day15 | 388.19 | 63 |
GSM1296035 | R_lesional_day15 | 899.67 | 77 |
GSM1296038 | U_lesional_day15 | 906.2 | 77 |
GSM1296047 | B_lesional_day15 | 670.51 | 73 |
GSM1296039 | E_lesional_day15 | 1004.69 | 79 |
GSM1296042 | H_lesional_day15 | 490.79 | 67 |
GSM1296043 | L_lesional_day15 | 397.98 | 63 |
GSM1296037 | M_lesional_day15 | 787.32 | 75 |
GSM1296046 | P_lesional_day15 | 617.23 | 71 |
GSM1296044 | Q_lesional_day15 | 605.38 | 71 |
GSM1296045 | Y_lesional_day15 | 615.87 | 71 |
GSM1296025 | C_lesional_day15 | 252.96 | 57 |
GSM1296033 | D_lesional_day15 | 730.26 | 74 |
GSM1296027 | I_lesional_day15 | 698.04 | 73 |
GSM1296032 | J_lesional_day15 | 606.73 | 71 |
GSM1296024 | K_lesional_day15 | 550.97 | 69 |
GSM1296031 | W_lesional_day15 | 1060.82 | 80 |
GSM1296028 | X_lesional_day15 | 700.73 | 73 |
GSM1296029 | Z_lesional_day15 | 750.97 | 74 |
GSM1296026 | F_lesional_day15 | 430 | 66 |
GSM1296030 | O_lesional_day15 | 875.87 | 77 |
GSM1296040 | S_lesional_day15 | 690.55 | 73 |
GSM1296036 | T_lesional_day15 | 276.5 | 57 |
GSM1296048 | V_lesional_day15 | 777.19 | 75 |
GSM1296059 | A_lesional_day43 | 521.4 | 68 |
GSM1296066 | G_lesional_day43 | 313.57 | 59 |
GSM1296060 | R_lesional_day43 | 704.06 | 73 |
GSM1296063 | U_lesional_day43 | 1007.26 | 79 |
GSM1296064 | E_lesional_day43 | 813.48 | 76 |
GSM1296067 | H_lesional_day43 | 506.93 | 67 |
GSM1296062 | M_lesional_day43 | 341.44 | 61 |
GSM1296068 | Q_lesional_day43 | 449.21 | 65 |
GSM1296050 | C_lesional_day43 | 360.37 | 63 |
GSM1296057 | D_lesional_day43 | 683.27 | 73 |
GSM1296052 | I_lesional_day43 | 687.8 | 73 |
GSM1296054 | J_lesional_day43 | 494.47 | 67 |
GSM1296049 | K_lesional_day43 | 567.19 | 70 |
GSM1296055 | W_lesional_day43 | 935.32 | 78 |
GSM1296053 | X_lesional_day43 | 691.9 | 73 |
GSM1296058 | Z_lesional_day43 | 773.24 | 75 |
GSM1296051 | F_lesional_day43 | 662.91 | 73 |
GSM1296056 | O_lesional_day43 | 1144.34 | 81 |
GSM1296065 | S_lesional_day43 | 542.09 | 69 |
GSM1296061 | T_lesional_day43 | 301.21 | 59 |
GSM1296095 | A_non-lesional_pre-dose | 739.76 | 74 |
GSM1296120 | B_non-lesional_pre-dose | 834.9 | 76 |
GSM1296077 | C_non-lesional_pre-dose | 404.05 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 462.31 | 66 |
GSM1296104 | E_non-lesional_pre-dose | 892.4 | 77 |
GSM1296079 | F_non-lesional_pre-dose | 449.89 | 66 |
GSM1296108 | G_non-lesional_pre-dose | 435.47 | 65 |
GSM1296110 | H_non-lesional_pre-dose | 412.71 | 63 |
GSM1296081 | I_non-lesional_pre-dose | 570.15 | 70 |
GSM1296091 | J_non-lesional_pre-dose | 733.49 | 74 |
GSM1296075 | K_non-lesional_pre-dose | 518.99 | 69 |
GSM1296112 | L_non-lesional_pre-dose | 400.99 | 63 |
GSM1296100 | M_non-lesional_pre-dose | 632.25 | 71 |
GSM1296087 | O_non-lesional_pre-dose | 880.31 | 77 |
GSM1296118 | P_non-lesional_pre-dose | 420.35 | 64 |
GSM1296114 | Q_non-lesional_pre-dose | 550.53 | 69 |
GSM1296097 | R_non-lesional_pre-dose | 575.08 | 70 |
GSM1296106 | S_non-lesional_pre-dose | 455.49 | 66 |
GSM1296102 | U_non-lesional_pre-dose | 1113.36 | 81 |
GSM1296122 | V_non-lesional_pre-dose | 543.78 | 69 |
GSM1296089 | W_non-lesional_pre-dose | 958.13 | 78 |
GSM1296083 | X_non-lesional_pre-dose | 611.86 | 71 |
GSM1296116 | Y_non-lesional_pre-dose | 318.47 | 59 |
GSM1296085 | Z_non-lesional_pre-dose | 505.68 | 68 |